Article info
PDFAbstracts
Technology (including: robots for production, Incompatibilities, drug production and analytics, CRS)
Proteomic approach to investigating the molecular integrity of rituximab when diluted in typical hospital conditions
Citation
Proteomic approach to investigating the molecular integrity of rituximab when diluted in typical hospital conditions
Publication history
- First published March 12, 2012.
Online issue publication
March 08, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions